PeterLabs Holdings Bhd (0171) - Total Assets
Based on the latest financial reports, PeterLabs Holdings Bhd (0171) holds total assets worth RM100.31 Million MYR (≈ $25.18 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See shareholders equity of PeterLabs Holdings Bhd for net asset value and shareholders' equity analysis.
PeterLabs Holdings Bhd - Total Assets Trend (2015–2024)
This chart illustrates how PeterLabs Holdings Bhd's total assets have evolved over time, based on quarterly financial data.
PeterLabs Holdings Bhd - Asset Composition Analysis
Current Asset Composition (December 2024)
PeterLabs Holdings Bhd's total assets of RM100.31 Million consist of 63.1% current assets and 36.9% non-current assets.
| Asset Category | Amount (MYR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | RM0.00 | 9.5% |
| Accounts Receivable | RM31.57 Million | 28.4% |
| Inventory | RM22.60 Million | 20.4% |
| Property, Plant & Equipment | RM30.03 Million | 27.1% |
| Intangible Assets | RM0.00 | 0.0% |
| Goodwill | RM9.96 Million | 9.0% |
Asset Composition Trend (2015–2024)
This chart illustrates how PeterLabs Holdings Bhd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 0171 stock market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: PeterLabs Holdings Bhd's current assets represent 63.1% of total assets in 2024, a decrease from 75.5% in 2015.
- Cash Position: Cash and equivalents constituted 9.5% of total assets in 2024, up from 0.0% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, an increase from 0.0% in 2015.
- Asset Diversification: The largest asset category is accounts receivable at 28.4% of total assets.
PeterLabs Holdings Bhd Competitors by Total Assets
Key competitors of PeterLabs Holdings Bhd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
GALDERMA GROUP AG
NYSE:GALDY
|
USA | $13.39 Billion |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
|
China | CN¥16.53 Billion |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
|
Germany | €1.60 Trillion |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518
|
China | CN¥13.68 Billion |
|
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773
|
China | CN¥10.21 Billion |
|
Shandong Lukang Pharmaceutical Co Ltd
SHG:600789
|
China | CN¥9.88 Billion |
|
Cronos Group Inc
TO:CRON
|
Canada | CA$1.18 Billion |
|
Hunan Warrant Pharmaceutical Co. Ltd. A
SHG:688799
|
China | CN¥2.53 Billion |
PeterLabs Holdings Bhd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.93 | 2.44 | 4.32 |
| Quick Ratio | 2.01 | 1.51 | 3.58 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | RM38.26 Million | RM44.47 Million | RM44.64 Million |
PeterLabs Holdings Bhd - Advanced Valuation Insights
This section examines the relationship between PeterLabs Holdings Bhd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.95 |
| Latest Market Cap to Assets Ratio | 0.15 |
| Asset Growth Rate (YoY) | -1.7% |
| Total Assets | RM111.03 Million |
| Market Capitalization | $16.58 Million USD |
Valuation Analysis
Below Book Valuation: The market values PeterLabs Holdings Bhd's assets below their book value (0.15x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: PeterLabs Holdings Bhd's assets decreased by 1.7% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for PeterLabs Holdings Bhd (2015–2024)
The table below shows the annual total assets of PeterLabs Holdings Bhd from 2015 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | RM111.03 Million ≈ $27.88 Million |
-1.66% |
| 2023-12-31 | RM112.91 Million ≈ $28.35 Million |
+6.29% |
| 2022-12-31 | RM106.22 Million ≈ $26.67 Million |
-4.79% |
| 2021-12-31 | RM111.57 Million ≈ $28.01 Million |
+51.94% |
| 2020-12-31 | RM73.43 Million ≈ $18.44 Million |
+0.96% |
| 2019-12-31 | RM72.73 Million ≈ $18.26 Million |
-0.11% |
| 2018-12-31 | RM72.81 Million ≈ $18.28 Million |
+5.64% |
| 2017-12-31 | RM68.92 Million ≈ $17.30 Million |
+11.62% |
| 2016-12-31 | RM61.75 Million ≈ $15.50 Million |
+22.27% |
| 2015-12-31 | RM50.50 Million ≈ $12.68 Million |
-- |
About PeterLabs Holdings Bhd
PeterLabs Holdings Berhad, an investment holding company, engages in manufacturing, distribution, trading, and export of animal health and nutrition products in Malaysia and internationally. The company operates through three segments: Manufacturing, Trading, and Others. It offers biosecurity products and disinfectants, compound feed supplements, feed additives, nutritional premixes, pharmaceutic… Read more